Crime Purdue Pharma Pleads Guilty in Criminal Case, Admits Hindering DEA from Fighting Opioid Epidemic

22:40  24 november  2020
22:40  24 november  2020 Source:   lawandcrime.com

Transfers provide at least some Ivy presence this season

  Transfers provide at least some Ivy presence this season Although the Ivy League won’t have a basketball season, a few of its most notable recent performers will be playing this year for new schools in different conferences. Former Harvard stars Bryce Aiken and Seth Towns, as well as ex-Yale standout Jordan Bruner, left as graduate transfers. Aiken headed to Seton Hall, Towns joined No. 23 Ohio State and Bruner opted to finish his career in Alabama. “I’m grateful for the opportunity to be here and have a potential season,” Aiken said during the Big East media event before the Ivy League officially pulled the plug on its 2020-21 season due to the coronavirus pandemic. © Provided by Associated Press File-This Feb.

Oxycontin maker Purdue Pharma has pleaded guilty today to three federal criminal charges as part of its .3 billion plea deal for its role in fueling America's This charge relates to Purdue impeding the Drug Enforcement Administration ( DEA ) by falsely representing that it had maintained an effective

US drugmaker Purdue Pharma pleaded guilty to three criminal charges over its production and sales of the prescription opioid Oxycontin, which stoked a nationwide addiction crisis, the Justice Department announced Wednesday.

Purdue Pharma, the maker of the medication OxyContin, pleaded guilty in a New Jersey federal court on Tuesday to three criminal charges, according to The Associated Press. They admitted to: hindering the U.S. Drug Enforcement Administration (DEA) from fighting the opioid epidemic; not maintaining a solid program to stop drugs from reaching the black market giving misleading information to the DEA in order to boost manufacturing quotas and paying doctors through a speakers program to encourage them to write out more painkiller prescriptions.

a sign on the side of a building © Provided by Law & Crime

Chairman Steve Miller appeared before the court.

Mexico threatened to expel DEA agents if US didn't reconsider charges against ex-defense minister: report

  Mexico threatened to expel DEA agents if US didn't reconsider charges against ex-defense minister: report Mexico threatened to expel agents from the Drug Enforcement Administration (DEA) if the U.S. did not reconsider charges against former Mexican defense minister Salvador Cienfuegos Zepeda, three people familiar with the case told The New York Times. The Justice Department announced on Tuesday that it would not seek charges against Cienfuegos and return him to Mexico after it opened its own investigation. Cienfuegos, who served in the role from 2012 to 2018, was arrested in Los Angeles last month on a DEA warrant and indicted on four counts of drug trafficking and money laundering.

US drugmaker Purdue Pharma pleaded guilty to three criminal charges over its production and sales of the prescription opioid Oxycontin, which stoked a Washington, (APP - UrduPoint / Pakistan Point News - 21st Oct, 2020 ) :US drugmaker Purdue Pharma pleaded guilty to three criminal charges

Purdue Pharma , the company that planted the seeds of the opioid epidemic through its aggressive marketing of OxyContin, has long claimed it was unaware In 2007, Purdue Pharma pleaded guilty to a felony charge of “misbranding” OxyContin while marketing the drug by misrepresenting, among

This is the result of a $8.3 billion dollar settlement in which the company would be remade into a public benefit company. The Sackler family gave up the company as part of the deal, and agreed to pay $225 million.

“The abuse and diversion of prescription opioids has contributed to a national tragedy of addiction and deaths, in addition to those caused by illicit street opioids,” said Deputy Attorney General Jeffrey A. Rosen back in October. “With criminal guilty pleas, a federal settlement of more than $8 billion, and the dissolution of a company and repurposing its assets entirely for the public’s benefit, the resolution in today’s announcement re-affirms that the Department of Justice will not relent in its multi-pronged efforts to combat the opioids crisis.”

The Pentagon isn't the only one with special operators. Here are the 5 most elite forces outside the military

  The Pentagon isn't the only one with special operators. Here are the 5 most elite forces outside the military Numerous US government agencies and departments have specially selected, manned, and trained units with some unique mission sets. Because of the Posse Comitatus Act, which makes it almost impossible to use the active-duty military in a domestic scenario, some of these units are the last line of defense in their respective jurisdictions.Here are the top 5:Hostage Rescue Team (FBI) © FBI HRT operators conducting close-quarters battle training. FBI The HRT specializes on domestic counterterrorism and hostage rescue.

Purdue Pharma could plead guilty to criminal charges in opioid probe. Neither Purdue nor the Sacklers have currently been charged with criminal wrongdoing or civil violations in the Justice Department investigations, and federal prosecutors have not yet decided whether to bring cases , they

Purdue Pharma , maker of the painkiller OxyContin, said its bankruptcy filing Sunday is part of an agreement to pay billions of dollars to states and local and tribal Purdue estimates after bankruptcy filings are complete, it will provide more than billion in funding to address the opioid crisis.

“The opioid epidemic remains a significant public health challenge that impacts the lives of men and women across the country,” said Gary L. Cantrell, the Deputy Inspector General for Investigations at the U.S. Department of Health and Human Services’ Office of Inspector General. “Unfortunately, Purdue’s reckless actions and violation of the law senselessly risked patients’ health and well-being. With our law enforcement partners, we will continue to combat the opioid crisis, including holding the pharmaceutical industry and its executives accountable.”

Federal officials called it a win, but critics, including a number of state attorneys general, said the settlement was a “spin.” No executives were charged as part of the deal. Neither were the Sacklers, the family that owns Purdue. The settlement only directly concerned the corporation as part of a resolution of certain criminal and civil investigations.

Trump turns on Pfizer over vaccine timing

  Trump turns on Pfizer over vaccine timing President Trump called a press briefing Friday to announce the implementation of his rules on drug pricing, which he said could save consumers hundreds or thousands of dollars a year, but got sidetracked on a rant against “big pharma,” which he blamed for sabotaging his reelection campaign because his policies would hurt their business. In particular, he attacked Pfizer, the largest drug company in the U.S., just two hours after his press secretary, Kayleigh McEnany, claimed credit for the development of Pfizer’s new COVID-19 vaccine on behalf of the administration’s “Operation Warp Speed” program.

Purdue Pharma , the maker of OxyContin, has reached a tentative deal with about half the states and thousands of local governments over its role in America’s deadly opioid epidemic Andrew Kolodny, an expert in the field of opioid addictions and the opioids crisis, said: “It’s bad because states will be

In 2007, Purdue pleaded guilty to federal charges of understating the risk of addiction and agreed to The board signed off on the three executives’ decisions to plead guilty . No member of the Sackler family The plea deals did little to hinder OxyContin sales or the Sacklers’ hands-on management.

“Many important issues undoubtedly get clouded by political considerations in a presidential election year,” wrote pharmaceutical industry expert Gerald Posner. “However, the many opioid victims and their families to whom I have spoken, would consider it an unforgiveable betrayal. It is a major miscalculation for the administration to believe that those Americans who have personally paid the price for the opioid epidemic want to see the architects of the crisis get a ‘get out of jail free’ card.”

“No one’s being held accountable for it,” author Barry Meier told Law&Crime in October. “No one is being charged with encouraging doctors to prescribe OxyContin unnecessarily when it wasn’t medically appropriate. After 20 years, it’s time to have this adjudicated in a courtroom rather than in a back room.”

Rhonda Schwartz and Ariel Tu contributed to this report.

[Image via Drew Angerer/Getty Images]

Money promised to combat US overdose crisis sits unused .
When it filed for bankruptcy last year, Purdue Pharma agreed to an innovative plan: It would make $200 million available immediately to help those those harmed by its signature painkiller, OxyContin, and ease the effects of the opioid crisis. More than a year later, with the crisis worsening, not a penny has been spent. “The money is just sitting in Purdue’s bank account collecting dust,” said Ed Neiger, a lawyer representing opioid victims. “It’s a travesty of epic proportions.”It's not Purdue that is holding up the money. Instead, it's lawyers representing the wide range of entities suing the company who cannot agree how best to use it.

usr: 7
This is interesting!